Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Akobeng

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
International Journal of Molecular Sciences|January 19, 2020
Claudin-1, A Double-Edged Sword in CancerAjaz A Bhat, Najeeb Syed, Lubna Therachiyil, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 23, 2018
Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment ResponseVictoria M Merrick, Kajal Mortier, Linda J Williams, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
International Journal of Molecular Sciences|January 19, 2020
Claudin-1, A Double-Edged Sword in CancerAjaz A Bhat, Najeeb Syed, Lubna Therachiyil, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 23, 2018
Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment ResponseVictoria M Merrick, Kajal Mortier, Linda J Williams, et al.
Pageof 2